Drug Type Small molecule drug |
Synonyms 제뉴원씨코바액 |
Target- |
Action- |
Mechanism Vitamin C supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (16 Oct 2024), |
Regulation- |
Molecular FormulaC6H8O6 |
InChIKeyCIWBSHSKHKDKBQ-JLAZNSOCSA-N |
CAS Registry50-81-7 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Epistaxis | South Korea | 16 Oct 2024 | |
| Gingival Hemorrhage | South Korea | 16 Oct 2024 | |
| Skin Pigmentation | South Korea | 16 Oct 2024 |





